Marshall Urist Royalty Pharma PLC (RPRX) insider trading activity

RPRX Quotes by TradingView

Marshall Urist is EVP, Research & Investments of Royalty Pharma plc. Currently has a direct ownership of 46,667 shares of RPRX, which is worth approximately $1.22 Million. The most recent transaction as insider was on Feb 22, 2023, when has been sold 23,333 shares (Class A Ordinary Shares) at a price of $37.3 per share, resulting in proceeds of $870,320. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.7K
0% 3M change
0% 12M change
Total Value Held $1.22 Million

Marshall Urist Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 22 2023
SELL
Open market or private sale
$870,320 $37.3 p/Share
23,333 Reduced 33.33%
46,667 Class A Ordinary Shares
Feb 17 2023
BUY
Conversion of derivative security
-
70,000 Added 50.0%
70,000 Class A Ordinary Shares
Jul 26 2022
SELL
Open market or private sale
$852,509 $43.2 p/Share
19,734 Reduced 100.0%
0 Class A Ordinary Shares
Jul 25 2022
SELL
Open market or private sale
$154,980 $43.05 p/Share
3,600 Reduced 15.43%
19,734 Class A Ordinary Shares
Jun 24 2022
SELL
Open market or private sale
$1,007,752 $43.19 p/Share
23,333 Reduced 50.0%
23,334 Class A Ordinary Shares
May 16 2022
SELL
Open market or private sale
$929,820 $39.85 p/Share
23,333 Reduced 33.33%
46,667 Class A Ordinary Shares
May 11 2022
BUY
Conversion of derivative security
-
70,000 Added 50.0%
70,000 Class A Ordinary Shares
Jun 07 2021
SELL
Open market or private sale
$779,027 $47.02 p/Share
16,568 Reduced 100.0%
0 Class A Ordinary Shares
Jun 04 2021
SELL
Open market or private sale
$747,624 $45.13 p/Share
16,566 Reduced 50.0%
16,568 Class A Ordinary Shares
Jun 02 2021
SELL
Open market or private sale
$604,780 $41.52 p/Share
14,566 Reduced 30.54%
33,134 Class A Ordinary Shares
May 21 2021
SELL
Open market or private sale
$4,100 $41.0 p/Share
100 Reduced 0.21%
47,700 Class A Ordinary Shares
May 20 2021
SELL
Open market or private sale
$78,052 $41.08 p/Share
1,900 Reduced 3.82%
47,800 Class A Ordinary Shares
May 07 2021
BUY
Conversion of derivative security
-
49,700 Added 50.0%
49,700 Class A Ordinary Shares
MU

Marshall Urist

EVP, Research & Investments
New York, NY

Track Institutional and Insider Activities on RPRX

Follow Royalty Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPRX shares.

Notify only if

Insider Trading

Get notified when an Royalty Pharma PLC insider buys or sells RPRX shares.

Notify only if

News

Receive news related to Royalty Pharma plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPRX